Key Details
Annual ROE
-258.99%Beta
-Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
Aug 14, 2024Recent annual earnings:
Apr 16, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Apr 12, 2023Analyst ratings
Recent major analysts updates
Screeners with VBIV included
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
Similar stocks
VBI Vaccines Inc. said Wednesday the first clinical data from a Phase I trial of a pan-coronavirus vaccine candidate produced broad and durable protection against variants of concern.
VBI Vaccines (NASDAQ: VBIV ) stock is taking a beating on Thursday after the pharmaceutical company announced two stock offerings. VBI Vaccines announced both a public stock offering and a registered directing offering for shares of VBIV stock.
VBI Vaccines, Inc. (VBIV) came out with a quarterly loss of $2.43 per share versus the Zacks Consensus Estimate of a loss of $2.27. This compares to loss of $2.40 per share a year ago.
VBI Vaccines (VBIV) will focus on its HBV vaccine product and advancing its HBV immunotherapeutic candidate. It will also reduce the workforce by 30-35% and initiate a 1-for-30 reverse stock split.
VBI Vaccines Inc. VBIV, -0.96% said Tuesday it is planning to focus its efforts on hepatitis B, as part of a reorganization that will see it cut operating costs and headcount by 30% to 35% and conduct a reverse stock split. Cambridge, Mass.
FAQ
- What is the primary business of VBI Vaccines?
- What is the ticker symbol for VBI Vaccines?
- Does VBI Vaccines pay dividends?
- What sector is VBI Vaccines in?
- What industry is VBI Vaccines in?
- What country is VBI Vaccines based in?
- When did VBI Vaccines go public?
- Is VBI Vaccines in the S&P 500?
- Is VBI Vaccines in the NASDAQ 100?
- Is VBI Vaccines in the Dow Jones?
- When was VBI Vaccines's last earnings report?
- When does VBI Vaccines report earnings?
- Should I buy VBI Vaccines stock now?